Additional file 1: Table S1. of An immune stratification reveals a subset of PD-1/LAG-3 double-positive triple-negative breast cancers

Patient characteristics. Table S2. Antibodies and immunostaining protocols. Table S3. Associations between tumor-infiltrating lymphocytes and clinicopathological features in triple-negative breast cancer (n = 259). Table S4. Associations between tumor-infiltrating lymphocytes and clinicopathological features in triple-negative breast cancer (validation cohort; n = 104). Table S5. Univariate Cox regression analysis of FOXP3 for relapse-free survival and overall survival in triple-negative breast cancer (n = 259) stratified by CD8+ tumor-infiltrating lymphocytes status. (PDF 90 kb)